Medical Properties Trust grants 112,500 shares to executive

Hanna James Kevin reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hanna James Kevin reported acquisition or exercise transactions in this Form 4 filing.

Medical Properties Trust granted equity awards to Senior VP, Controller & CAO James Kevin Hanna. He received 75,000 shares of common stock as a time-based award and 37,500 performance-based shares tied to debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028. Following these grants, he directly holds 546,794 shares of common stock. The time-based shares vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026, while the performance award will be earned only if specific performance thresholds are achieved.

Insider Trade Summary

Grant/Award: 112,500 shares

Grant/Award 2 txns

Insider Hanna James Kevin

Role Senior VP, Controller & CAO

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	75,000	$0.00	$0.00
Grant/Award	Common stock, par value $0.001	37,500	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 546,794 shares (Direct)

Footnotes (2)

1. F1. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.
2. F2. Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MEDICAL PROPERTIES TRUST (MPT) report for James Kevin Hanna?

Medical Properties Trust reported that Senior VP, Controller & CAO James Kevin Hanna received equity awards totaling 112,500 common shares. These consist of time-based and performance-based grants, both awarded at no cash purchase price as part of his compensation package.

How many MEDICAL PROPERTIES TRUST (MPT) shares were granted to the executive on March 18, 2026?

On March 18, 2026, James Kevin Hanna was granted 75,000 time-based common shares and 37,500 performance-based common shares. Together, these awards total 112,500 shares of Medical Properties Trust common stock at a grant price of $0.0000 per share.

How do the time-based MEDICAL PROPERTIES TRUST (MPT) shares vest for this Form 4 grant?

The 75,000 time-based shares vest ratably at the beginning of each of 12 calendar quarters starting April 1, 2026. This means equal portions of the award become owned over three years, assuming continued service and any applicable conditions are satisfied.

What performance goals affect the 37,500 MEDICAL PROPERTIES TRUST (MPT) performance-based shares?

The 37,500 performance-based shares will be earned based on specific thresholds for reducing overall company debt and increasing cash revenue growth between January 1, 2026 and December 31, 2028. The actual shares issued will vary with achievement against these committee-set metrics.

How many MEDICAL PROPERTIES TRUST (MPT) shares does James Kevin Hanna own after these grants?

After the reported equity grants, James Kevin Hanna directly holds 546,794 shares of Medical Properties Trust common stock. This figure reflects his updated position following the addition of the 37,500 performance-based shares reported in the second line of the Form 4.

Are the MEDICAL PROPERTIES TRUST (MPT) Form 4 grants open-market purchases or compensation awards?

The reported transactions are compensation-related awards, not open-market purchases. Both entries use transaction code “A” for grants or awards, show a per-share price of $0.0000, and are tied to time-based vesting and performance conditions set by the compensation committee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanna James Kevin

(Last) (First) (Middle)

10500 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP, Controller & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	03/18/2026		A		75,000(1)	A	$0	509,294	D
Common stock, par value $0.001	03/18/2026		A		37,500(2)	A	$0	546,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

2. Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

	W. Zachary Riddle, by power of attorney	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)